USP12 can regulate p65 deubiquitination in the NF-κB signaling pathway in MDSCs, thereby mediating PD-L1 and iNOS expression and the anti-tumor immune response of CD4+ T cells. This evidence concerns the gene NFKB1 and neoplasm.